Trial Site Detail
Drug: |
Nilotinib |
|||
|---|---|---|---|---|
Trial: |
Efficacy and Safety of AMN107 Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib - Extension |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Washington Cancer Institute110 Irving St |
Principal Investigator: |
|
|---|---|
Contact: |
Jake Paterson, 202 877-5371 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Washington Cancer Institute Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.